Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0068 | 0.0146 |
Trichomonas vaginalis | set domain proteins, putative | 0.0251 | 0.5346 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0364 | 0.0783 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0174 | 0.3597 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0765 | 0.1643 |
Mycobacterium leprae | PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) | 0.0456 | 1 | 0.5 |
Plasmodium vivax | SET domain protein, putative | 0.0032 | 0.0364 | 0.0298 |
Plasmodium vivax | peptide deformylase, putative | 0.0456 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | peptide deformylase | 0.0456 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0411 | 0.0883 |
Toxoplasma gondii | hypothetical protein | 0.0456 | 1 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.022 | 0.4654 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.022 | 0.4654 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0068 | 0.5 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.003 | 0.0338 | 0.9275 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0411 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0411 | 0.0883 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0032 | 0.0364 | 1 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0174 | 0.3597 | 1 |
Mycobacterium ulcerans | peptide deformylase | 0.0456 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0068 | 0.1657 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0364 | 0.8867 |
Leishmania major | polypeptide deformylase-like protein, putative | 0.0174 | 0.3597 | 1 |
Treponema pallidum | polypeptide deformylase (def) | 0.0456 | 1 | 1 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0032 | 0.0364 | 0.0298 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0174 | 0.3597 | 1 |
Onchocerca volvulus | 0.0251 | 0.5346 | 1 | |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0032 | 0.0364 | 1 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0032 | 0.0364 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.0765 | 0.1643 |
Brugia malayi | Pre-SET motif family protein | 0.0032 | 0.0364 | 0.0783 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0174 | 0.3597 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.0765 | 0.1643 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0.0068 | 0.5 |
Plasmodium falciparum | peptide deformylase | 0.0456 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.0765 | 0.1643 |
Trypanosoma brucei | Peptide deformylase 2 | 0.0174 | 0.3597 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0068 | 0.1869 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0364 | 0.8867 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0068 | 0.1869 |
Mycobacterium tuberculosis | Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) | 0.0456 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0068 | 0.1657 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0068 | 0.0146 |
Trypanosoma brucei | Polypeptide deformylase 1 | 0.0174 | 0.3597 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0032 | 0.0364 | 0.8867 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0364 | 0.8867 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.